Tweet #470879894067773440

Efficacy and safety of a new monophasic HA #dermalfiller for NLF’s: a randomized, evaluator-blinded, split-face study ncbi.nlm.nih.gov/pubmed/23789873

From Twitter Web Client 5:51am May 26 2014 —